Global Inhalation Anesthetics Market

Inhalation anesthetics are a group of drugs used to induce a state of unconsciousness during medical procedures, such as surgery. These anesthetics are usually administered through inhalation using a mask or a breathing tube and work by depressing the central nervous system, resulting in a loss of consciousness, pain sensation, and muscle tone. The analysis predicts the global inhalation anesthetics market will grow from USD 1,259.0 million in 2022 to USD 1,734.1 million by 2029, achieving a compound annual growth rate (CAGR) of 4.68 percent.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global inhalation anesthetics market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, end user, and region. The global market for inhalation anesthetics can be segmented by type: desflurane, sevoflurane, isoflurane, others. Among these, the sevoflurane segment was accounted for the highest revenue generator in 2022. Inhalation anesthetics market is further segmented by end user: hospitals, ambulatory surgical centers, others. The ambulatory surgical centers segment is estimated to account for the largest share of the global inhalation anesthetics market. Based on region, the inhalation anesthetics market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America held the largest share of the global inhalation anesthetics market in 2022 and is anticipated to hold its share during the forecast period.

Market Segmentation
By type: desflurane, sevoflurane, isoflurane, others
By end user: hospitals, ambulatory surgical centers, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report has also analysed the competitive landscape of the global inhalation anesthetics market with some of the key players being Abbvie Inc., Baxter International Inc., Piramal Enterprises Ltd., Hikma Pharmaceuticals plc, Merck KGaA, Fresenius Kabi AG, Dechra Pharmaceuticals plc, Jiangsu Hengrui Pharmaceuticals Co., Ltd., Lunan Pharmaceutical Group, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global inhalation anesthetics market.
• To classify and forecast the global inhalation anesthetics market based on type, end user, region.
• To identify drivers and challenges for the global inhalation anesthetics market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global inhalation anesthetics market.
• To identify and analyze the profile of leading players operating in the global inhalation anesthetics market.

Why Choose This Report
• Gain a reliable outlook of the global inhalation anesthetics market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Global Inhalation Anesthetics Market

Interested in this report? Get your FREE sample now!
Global Inhalation Anesthetics Market - Report Scope
REPORT ATTRIBUTE

DETAILS

Base Year

2022

Forecast Year

2023-2029

CAGR (2023-2029)

4.68%

Pages

86

Key Players

Abbvie Inc., Baxter International Inc., Piramal Enterprises Ltd., Hikma Pharmaceuticals plc, Merck KGaA, Fresenius Kabi AG, Dechra Pharmaceuticals plc, Jiangsu Hengrui Pharmaceuticals Co. Ltd., Lunan Pharmaceutical Group

Related Reports
China Skin Care and Treatment Market 2023

The skin care and treatment market in China, in terms of revenue, is expected to grow by 9.9 percent annually through 2029, according to the latest estimates. Skin care is essential for maintaining skin health and preventing skin conditions. It helps to protect the skin from environmental factors, such as…

READ MORE
China Skin-related Beauty Market 2023

According to the latest research, the skin-related beauty market in China is estimated to increase at the rate of 10.1% each year in the period from 2023 to 2029. Skin-related beauty refers to the products and treatments aimed at improving the health, appearance, and overall condition of the skin. It…

READ MORE
Global Suction Catheter Market

Global suction catheter market by product (closed suction catheter, open suction catheter), by region (Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America), outlook & forecast, 2023-2029

READ MORE

$2,650.00

Want to customize this report?
The present report possesses the flexibility to be tailored to your specific needs. Our team of analysts and industry experts will collaborate directly with you to gain a comprehensive understanding of your requirements.
Scroll to Top

Download Free Sample - Global Inhalation Anesthetics Market

Please fill out our form and we will get back to you.